FABP4 and breast carcinoma: A reduction in lipid proteins, including fatty acid binding protein 4, which regulates inflammatory and metabolic processes in adipocytes and TAMs, led to reduced metastasis and enhanced sensitivity to chemotherapy in breast cancer xenografts [27].